Showing results (281-290 of 1,303) with videos related to
Sort By:
Pageof 131
Journal of Gynecologic Oncology|March 1, 2024
The efficacy of the levonorgestrel intrauterine system versus oral megestrol acetate in treating atypical endometrial hyperplasia: a superior randomized controlled trialAmr A Alnemr, Ola A Harb, Hytham AtiaJournal of Gynecologic Oncology|April 12, 2024
Comprehensive characterization of genomic features and clinical outcomes following targeted therapy and secondary cytoreductive surgery in OCCC: a single center experienceSilvana Talisa Wijaya, Natalie Yl Ngoi, Jerold Wz Loh, et al.Journal of Gynecologic Oncology|April 5, 2024
Mirvetuximab soravtansine in platinum-resistant recurrent ovarian cancer with high folate receptor-alpha expression: a cost-effectiveness analysisYouwen Zhu, Yinxin Lin, Kun Liu, et al.Journal of Gynecologic Oncology|April 5, 2024
Patient and clinician priorities for information on treatment outcomes for advanced ovarian cancer: a Delphi exerciseKathryn Baxter, Heather Agnew, Jennie Morgan, et al.Journal of Gynecologic Oncology|May 24, 2024
A phase II trial evaluating the efficacy and safety of repeated high dose medroxyprogesterone acetate (MPA) therapy for patients with recurrent early-stage endometrial cancer or atypical endometrial hyperplasia: Japanese Gynecologic Oncology Group study (JGOG2051/KGOG2031, REMPA trial)Kensuke Sakai, Wataru Yamagami, Yasunori Sato, et al.Journal of Gynecologic Oncology|May 10, 2024
Comparison of postoperative adjuvant platinum-based chemotherapy and no further therapy after radical surgery in intermediate-risk early-stage cervical cancerHiroki Nishimura, Tsukuru Amano, Yutaka Yoneoka, et al.Journal of Gynecologic Oncology|May 10, 2024
Unveiling pembrolizumab effectiveness in diverse subtypes of MSI-high endometrial cancersRisako Ozawa, Tadaaki Nishikawa, Hiroshi Yoshida, et al.Journal of Gynecologic Oncology|April 26, 2024
LncRNA STARD7-AS1 suppresses cervical cancer cell proliferation while promoting autophagy by regulating miR-31-5p/TXNIP axis to inactivate the mTOR signalingXiyao Yin, Xin Liu, Hui Gong, et al.Journal of Gynecologic Oncology|April 26, 2024
Efficacy and safety of combined anlotinib-oral etoposide treatment for patients with platinum-resistant ovarian cancerShuai Huang, Guihua Sheng, Qiubo Lv, et al.Journal of Gynecologic Oncology|May 6, 2024
Genetic analysis of cervical cancer with lymph node metastasisHao He, Misi He, Qi Zhou, et al.Pageof 131